News Image

ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy

Provided By GlobeNewswire

Last update: Mar 8, 2024

Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched control group receiving conventional stroke therapy.

Read more at globenewswire.com

LIFEWARD LTD

NASDAQ:LFWD (8/29/2025, 8:00:02 PM)

After market: 0.65 +0.02 (+2.39%)

0.6348

+0.01 (+2.37%)



Find more stocks in the Stock Screener

LFWD Latest News and Analysis

Follow ChartMill for more